1-(5-(Trifluoromethyl)pyridin-2-yl)piperidin-4-amine → 1-(4-Trifluoromethylthiazol-2-yl)piperidin-4-ylamine
Reaktionsgleichung
FC(F)(F)C1C=CC([N:9]2[CH2:14][CH2:13][CH:12]([NH2:15])[CH2:11][CH2:10]2)=NC=1.Br[C:19]1[S:20][CH:21]=[C:22]([C:24]([F:27])([F:26])[F:25])[N:23]=1.C(OC(=O)N[C@@H]1CCN(C2C(C(F)(F)F)=CC=CN=2)C1)(C)(C)C.FC(F)(F)C1C(N2CC[C@@H](N)C2)=NC=CC=1>>[F:25][C:24]([F:27])([F:26])[C:22]1[N:23]=[C:19]([N:9]2[CH2:14][CH2:13][CH:12]([NH2:15])[CH2:11][CH2:10]2)[S:20][CH:21]=1Komponenten
5
Edukt 4
Produkt 1
Versuchsvorschrift
Prepared from D8 and 2-bromo4-trifluoromethylthiazole (J. A. Edwards Ger. Offen., 2252070, 1973) in a manner similar to that described in D1 and D2. The following were prepared using methods described above and in a manner similar to that of D18:
Aufarbeitung
- customThe following were prepared
Quellen und Nachweise
- ORD-Eintrag
- ord-a26077184d90414ea295d68383d97a35
- Quelldatensatz
- uspto-grants-2009_05
- Patentnummer
- US07528151B2
Notizen zur Reaktion
Wird geladen…